Extra-cellular signal-regulated ERK-1/ERK-2 pathway activation in human salivary gland mucoepidermoid carcinoma: Association to aggressive tumor behavior and tumor cell proliferation

American Journal of Pathology

Volumn 163, Issue 3, 2003, Pages 957-967

  Handra Luca, Adriana ^a   Bilal, Hadi ^a   Bertrand, Jacques Charles ^a   Fouret, Pierre ^b,c  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE 1; PROTEIN P16;

ARTICLE; CELL PROLIFERATION; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MUCOEPIDERMOID TUMOR; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SALIVARY GLAND CARCINOMA; SIGNAL TRANSDUCTION;

EID: 0041423399     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)63455-4     Document Type: Article

References (40)

1. Ellis GL, Auclair PL: Mucoepidermoid carcinoma. Tumors of the Salivary Glands. Edited by Rosai J, Sobin LH. Washington, DC, Armed Forces Institute of Pathology, 1996, pp 155-172
2. Sessions R, Harrison L, Forastiere A: Tumors of the salivary glands and paragangliomas. Cancer: Principles and Practice of Oncology, ed 6. Edited by De Vita VT, Hellman S, Rosenberg SA. Philadelphia, PA, Lippicott Williams and Wilkins, 2000, pp 886-900
3. Goode RK, Auclair PL, Ellis GL: Mucoepidermoid carcinoma of the major salivary glands: clinical and histopathologic analysis of 234 cases with evaluation of grading criteria. Cancer 1998, 82:1217-1224
4. Auclair PL, Goode RK, Ellis GL: Mucoepidermoid carcinoma of intraoral salivary glands: evaluation and application of grading criteria in 143 cases. Cancer 1992, 69:2021-2030
5. Dardick I, Gliniecki MR, Heathcote JG, Burford-Mason A: Comparative histogenesis and morphogenesis of mucoepidermoid carcinoma and pleomorphic adenoma: an ultrastructural study. Virchows Arch A Pathol Anat Histopathol 1990, 417:405-417
6. Stenman G, Sandros J, Dahlenfors R, Juberg-Ode M, Mark J: 6q- and loss of the Y chromosome: two common deviations in malignant human salivary gland tumors. Cancer Genet Cytogenet 1986, 22:283-293
7. Jin C, Martins C, Jin Y, Wiegant J, Wennerberg J, Dictor M, Gisselsson D, Strombeck B, Fonseca I, Mitelman F, Tanke HJ, Hoglund M, Mertens F: Characterization of chromosome aberrations in salivary gland tumors by FISH, including multicolor COBRA-FISH. Genes Chromosomes Cancer 2001, 30:161-167
8. el-Naggar AK, Lovell M, Killary AM, Batsakis JG: Genotypic characterization of a primary mucoepidermoid carcinoma of the parotid gland by cytogenetic, fluorescence in situ hybridization, and DNA ploidy analysis. Cancer Genet Cytogenet 1996, 89:38-43
9. Press MF, Pike MC, Hung G, Zhou JY, Ma Y, George J, Dietz-Band J, James W, Slamon DJ, Batsakis JG, El-Naggar AK: Amplification and overexpression of HER-2/neu in carcinomas of the salivary gland: correlation with poor prognosis. Cancer Res 1994, 54:5675-5682
10. Yoo J, Robinson RA: H-ras gene mutations in salivary gland mucoepidermoid carcinomas. Cancer 2000, 88:518-523
11. Cantley LC, Auger KR, Carpenter C, Duckworth B, Graziani A, Kapeller R, Soltoff S: Oncogenes and signal transduction. Cell 1991, 64:281-302
12. Seger R, Krebs EG: The MAPK signaling cascade. EMBO J 1995, 9:726-735
13. Lewis TS, Shapiro PS, Ahn NG: Signal transduction through MAP kinase cascades. Adv Cancer Res 1998, 74:49-139
14. Johnson GL, Lapadat R: Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 2002, 298:1911-1912
15. Leevers SJ, Marshall CJ: Activation of extracellular signal-regulated kinase, ERK2, by p21ras oncoprotein. EMBO J 1992, 11:569-574
16. Sebolt-Leopold JS: Development of anticancer drugs targeting the MAP kinase pathway. Oncogene 2000, 19:6594-6599
17. Schmidt M, Goebeler M, Posern G, Feller SM, Seitz CS, Brocker EB, Rapp UR, Ludwig S: Ras-independent activation of the Raf/MEK/ERK pathway upon calcium-induced differentiation of keratinocytes. J Biol Chem 2000, 275:41011-41017
18. Loda M, Capodieci P, Mishra R, Yao H, Corless C, Grigioni W, Wang Y, Magi-Galluzzi C, Stork PJ: Expression of mitogen-activated protein kinase phosphatase-1 in the early phases of human epithelial carcinogenesis. Am J Pathol 1996, 149:1553-1564
19. Magi-Galluzzi C, Mishra R, Fiorentino M, Montironi R, Yao H, Capodieci P, Wishnow K, Kaplan I, Stork PJ, Loda M: Mitogen-activated protein kinase phosphatase 1 is overexpressed in prostate cancers and is inversely related to apoptosis. Lab Invest 1997, 76:37-51
20. Oka H, Chatani Y, Hoshino R, Ogawa O, Kakehi Y, Terachi T, Okada Y, Kawaichi M, Kohno M, Yoshida O: Constitutive activation of mitogen-activated protein (MAP) kinases in human renal cell carcinoma. Cancer Res 1995, 55:4182-4187
21. Adeyinka A, Nui Y, Cherlet T, Snell L, Watson PH, Murphy LC: Activated mitogen-activated protein kinase expression during human breast tumorigenesis and breast cancer progression. Clin Cancer Res 2002, 8:1747-1753
22. Albanell J, Codony-Servat J, Rojo F, Del Campo JM, Sauleda S, Anido J, Raspall G, Giralt J, Rosello J, Nicholson RI, Mendelsohn J, Baselga J: Activated extracellular signal-regulated kinases: association with epidermal growth factor receptor/transforming growth factor α expression in head and neck squamous carcinoma and inhibition by anti-epidermal growth factor receptor treatments. Cancer Res 2001, 61:6500-6510
23. Mandell JW, Hussaini IM, Zecevic M, Weber MJ, VandenBerg SR: In situ visualization of intratumor growth factor signaling: immunohistochemical localization of activated ERK/MAP kinase in glial neoplasms. Am J Pathol 1998, 153:1411-1423
24. Cohen C, Zavala-Pompa A, Sequeira JH, Shoji M, Sexton DG, Cotsonis G, Cerimele F, Govindaraian B, Macaron N, Arbiser JL: Mitogen-actived protein kinase activation is an early event in melanoma progression. Clin Cancer Res 2002, 8:3728-3733
25. Malik SN, Brattain M, Ghosh PM, Troyer DA, Prihoda T, Bedolla R, Kreisberg JI: Immunohistochemical demonstration of phospho-Akt in high Gleason grade prostate cancer. Clin Cancer Res 2002, 8:1168-1171
26. Li D, Lin HH, McMahon M, Ma H, Ann DK: Oncogenic raf-1 induces the expression of non-histone chromosomal architectural protein HMGI-C via a p44/ p42 mitogen-activated protein kinase-dependent pathway in salivary epithelial cells. J Biol Chem 1997, 272:25062-25070
27. Kharitonenkov A, Chen Z, Sures I, Wang H, Schilling J, Ullrich A: A family of proteins that inhibit signalling through tyrosine kinase receptors. Nature 1997, 386:181-186
28. Brandwein MS, Ivanov K, Wallace DI, Hille JJ, Wang B, Fahmy A, Bodian C, Urken ML, Gnepp DR, Huvos A, Lumerman H, Mills SE: Mucoepidermoid carcinoma: a clinicopathologic study of 80 patients with special reference to histological grading. Am J Surg Pathol 2001, 25:835-845
29. Noguchi T, Dobashi Y, Minehara H, Itoman M, Kameya T: Involvement of cyclins in cell proliferation and their clinical implications in soft tissue smooth muscle tumors. Am J Pathol 2000, 156:2135-2147
30. Lebeau A, Deimling D, Kaltz C, Sendelhofert A, Iff A, Luthardt B, Untch M, Lohrs U: Her-2/neu analysis in archival tissue samples of human breast cancer: comparison of immunohistochemistry and fluorescence in situ hybridization. J Clin Oncol 2001, 19:354-363
31. Klussmann JP, Gultekin E, Weissenborn SJ, Wieland U, Dries V, Dienes HP, Eckel HE, Pfister HJ, Fuchs PG: Expression of p16 protein identifies a distinct entity of tonsillar carcinomas associated with human papillomavirus. Am J Pathol 2003, 162:747-753
32. Al-Haddad S, Zhang Z, Leygue E, Snell L, Huang A, Niu Y, Hiller-Hitchcock T, Hole K, Murphy LC, Watson PH: Psoriasin (S100A7) expression and invasive breast cancer. Am J Pathol 1999, 155:2057-2066
33. Soria JC, Morat L, Commo F, Dabit D, Perie S, Sabatier L, Fouret P: Telomerase activation cooperates with inactivation of p16 in early head and neck tumorigenesis. Br J Cancer 2001, 84:504-511
34. van Rossum GS, Klooster R, van den Bosch H, Verkleij AJ, Boonstra J: Phosphorylation of p42/44(MAPK) by various signal transduction pathways activates cytosolic phospholipase A(2) to variable degrees. J Biol Chem 2001, 276:28976-28983
35. Govindarajan B, Klafter R, Miller MS, Mansur C, Mizesko M, Bai X, LaMontagne Jr K, Arbiser JL: Reactive oxygen-induced carcinogenesis causes hypermethylation of p16(Ink4a) and activation of MAP kinase. Mol Med 2002, 8:1-8
36. Hughes PE, Renshaw MW, Pfaff M, Forsyth J, Keivens VM, Schwartz MA, Ginsberg MH: Suppression of integrin activation: a novel function of a Ras/Raf-initiated MAP kinase pathway. Cell 1997, 88:521-530
37. Yamada K, Iwai K, Okada Y, Mori M: Immunohistochemical expression of epidermal growth factor receptor in salivary gland tumours. Virchows Arch A Pathol Anat Histopathol 1989, 415:523-531
38. Press MF, Hung G, Godolphin W, Slamon DJ: Sensitivity of HER-2/neu antibodies in archival tissue samples: potential source of error in immunohistochemical studies of oncogene expression. Cancer Res 1994, 54:2771-2777
39. Seifert G, Sobin LH, and Pathologists in 6 countries: Histological Typing of Salivary Gland Tumours. Edited by Seifert G, Sobin LH. Berlin, Germany, Springer-Verlag, 1991, pp 20-21
40. Sebolt-Leopold JS, Dudley DT, Herrera R, Van Becelaere K, Wiland A, Gowan RC, Tecle H, Barrett SD, Bridges A, Przybranowski S, Leopold WR, Saltiel AR: Blockade of the MAP kinase pathway suppresses growth of colon tumors in vivo. Nat Med 1999, 5:810-816